Existing therapeutics for autoimmune diseases remain problematic due to low efficacy, severe side effects, and difficulties to reach target tissues. Herein, we design multifunctional fusion nanovesicles that can target lesions for the treatment of autoimmune skin diseases. The grapefruit‐derived exosome‐like nanovesicles (GEVs) with anti‐inflammatory and antioxidant effects are first encapsulated with CX5461, an immunosuppressant with anti‐proliferative properties to form GEV@CX5461. In order to enhance therapeutic efficiency and safety, GEV@CX5461 are then fused with CCR6+ nanovesicles derived from membranes of engineered gingiva‐derived mesenchymal stem cells (GMSCs). The resulting FV@CX5461 not only maintain the bioactivity of GEVs, CX5461, and GMSC membranes but also home to inflamed tissues rich in chemokine CCL20 through the chemotaxis function of CCR6 on FVs. Moreover, FV@CX5461 reduce the secretion of inflammatory factors, calm down Th17 cell activation, and induce Treg cell infiltration. Finally, impressive therapeutic efficiency in both psoriasis and atopic dermatitis disease models is demonstrated using FV@CX5461 to reshape the unbalanced immune microenvironment. A nanotherapeutic drug delivery strategy is developed using fusion nanovesicles derived from plant and animal cells with high clinical potential.
We highlight the recent progress and design strategies of polymeric materials with tailored functions to overcome the highly movable and wet, microbial and inflammatory environment in the oral cavity for treatment of oral diseases.
Nanozymes could mimic the catalytic activity of natural enzymes, then stimulate the Fenton reaction for reactive oxygen species overproduction and lipid peroxidation, ultimately induce ferroptosis to exert anticancer effects.
Maxillofacial bone defects can be caused by inflammation, surgical resection, tumor and other factors which seriously affect the human body's physiological and psychological function and social activities. Bone marrow mesenchymal stem cells (BMSCs) have the characteristics of self-renewal and multi-directional differentiation, so they are ideal seed cells for oral and maxillofacial repair and regeneration by tissue engineering. We previously found that wnt2b can promote the osteogenic differentiation of BMSCs, but its downstream mechanism is unclear. Through high-throughput sequencing and in vitro experiments, we confirmed that FZD5 could be bound by wnt2b and activate YAP/TAZ. Then through Western blot, immunofluorescence, alkaline phosphatase activity detection, alizarin red staining, and other in vivo and in vitro experiments confirmed that the Wnt2b/FZD5/G α q/11/YAP/TAZ signal axis is involved in the regulation of osteogenic differentiation of bone marrow mesenchymal stem cells. It is clarified that wnt2b regulates the osteogenic differentiation of BMSCS through noncanonical Wnt Signaling Pathway, which broadens the Wnt signaling pathway and provides a new theoretical basis for developing treatment for the treatment of oral and maxillofacial bone defects.
Melasma is a refractory pigmentary disorder increasingly recognized as a photoaging-related condition driven by a dysregulated dermal microenvironment, where oxidative stress acts as a central pathogenic hub; notably, in the context of skin photoaging, intracellular iron overload has been identified as a critical catalyst for oxidative damage via the Fenton reaction. To explore therapeutic strategies capable of remodeling this redox niche, we systematically investigated the efficacy and molecular mechanisms of an injectable cross-linked porcine type I collagen using an in vivo model of photoaging-induced hyperpigmentation. Transcriptomic profiling combined with multidimensional molecular validation revealed that the collagen implant not only effectively repairs damaged dermal architecture and reverses the hyperpigmented phenotype but also relies on a dual regulatory network for its efficacy. Specifically, the treatment transcriptionally represses melanogenesis by downregulating rate-limiting enzymes such as TYR and DCT, while simultaneously functioning as a biomimetic "Iron Trap" that re-establishes local iron homeostasis through chemically chelating labile tissue iron and biologically inducing FTH1 expression. This sequestration of pro-oxidant iron blocks the Fenton reaction and couples with the upregulation of GPX4 to bolster antioxidant defenses, thereby effectively curbing ferroptosis. Collectively, these findings demonstrate that the collagen scaffold fundamentally ameliorates the pathological microenvironment .